Back to search
FDAFDA · Food and drugs·Recall number D-1439-2012

Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye, Sterile Ophthalmic Solution, Rx Only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9

Published August 8, 2012 · Recall initiated: April 30, 2012

Summary

FDA records drug Class II recall D-1439-2012, published August 8, 2012 and initiated April 30, 2012. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 119,794 Bottles; Lot: Lot #s: JN1060, JN1061, JN1062, Exp 06/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Lots identified in this recall notification may contain small particulates.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #s: JN1060, JN1061, JN1062, Exp 06/12
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye, Sterile Ophthalmic Solution, Rx Only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9 recalled?

Yes. FDA published recall D-1439-2012 on August 8, 2012. Reported hazard: Presence of Particulate Matter: Lots identified in this recall notification may contain small particulates.

What should I do if I have this product?

Voluntary: Firm initiated · Letter